Inovox Na Kaszel Smak Miodowo-Cytrynowy

Dextromethorphan Hydrobromide, the active ingredient in Inovox Na Kaszel Smak Miodowo-Cytrynowy, is an antitussive presented as an oral formulation for oral use. It suppresses cough in patients with non‑productive coughs.

GNH USA supplies Inovox Na Kaszel Smak Miodowo-Cytrynowy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Dextromethorphan, an antitussive, is used to manage cough associated with the respiratory tract.

- Cough: reduces frequency and intensity of dry, non‑productive cough. - Upper respiratory tract infection: provides symptomatic relief of cough. - Bronchitis: helps control cough associated with acute bronchitis.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Nausea: mild stomach upset or urge to vomit. - Dizziness: sensation of light‑headedness or imbalance. - Dry mouth: reduced salivation causing throat discomfort.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Serotonin syndrome: agitation, fever, rapid heart rate when combined with serotonergic drugs. - Hallucinations: visual or auditory disturbances, especially at high doses. - Respiratory depression: slowed breathing in cases of overdose.

Before using this product, consider the following precautions: - Assess patient history: check for asthma, chronic lung disease, or other respiratory conditions. - Age restriction: avoid use in children under the recommended age unless directed by a healthcare professional. - Dose limitation: do not exceed the prescribed amount to prevent toxicity. - Drug interactions: exercise caution when the patient is taking MAO inhibitors or other serotonergic agents. - Alcohol avoidance: refrain from alcohol consumption as it may increase sedation. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Dextromethorphan may interact with several medicines. Review the following:

Major Interactions (Avoid): - MAO inhibitors: risk of severe serotonin syndrome. - Selective serotonin reuptake inhibitors (SSRIs): may precipitate serotonin toxicity. - Tricyclic antidepressants: increased risk of serotonin toxicity. - Other NMDA antagonists: additive central nervous system depression.

Moderate Interactions (Monitor Closely): - Alcohol: enhances drowsiness and sedation. - CNS depressants (e.g., benzodiazepines, opioids): may increase sedation. - Antihistamines: may increase drowsiness.